Cross-tissue analysis of blood and brain epigenome-wide association studies in Alzheimer’s disease

Study datasets

Our meta-analysis of blood samples included a total of 1284 DNA methylation samples (427 AD cases, 857 cognitive normals) from two large independent AD EWAS, the ADNI14 and the AIBL16 studies. The ADNI study is a longitudinal study with DNA methylation samples collected at baseline and multiple follow-up visits ranging from 6 months to 60 months14. The average and median times between the first and last visits for the subjects were 18 months and 24 months, respectively. Similarly, the AIBL study is also a longitudinal study with DNA methylation samples collected at 18-month follow-up. A total of 797 unique individuals older than 65 years of age were included in this study. The mean ages of the subjects were 77.13 (±6.64) years and 73.37 (±5.79) years, and the percentages of females were 46% and 54% in the ADNI and AIBL studies, respectively (Supplementary Data 1).

Read more…